Based on the data, which of the following best describes the relationship between cyclin-dependent kinases and the cell cycle?

Core Concept

PILLAR 1 — MOLECULAR/CONCEPTUAL MECHANISM

Step-by-Step Analysis

Cyclin-dependent kinases (CDKs) are serine/threonine protein kinases that exist as enzymatic scaffolds in the cytoplasm and nucleus throughout interphase and mitosis. Their catalytic domains remain conformationally inactive until a regulatory cyclin protein binds at a hydrophobic cleft on the CDK surface. This binding event reorients the activation loop (T-loop) of the CDK, exposing the ATP-binding pocket and allowing transfer of a phosphoryl group from ATP to specific serine or threonine residues on downstream substrate proteins. The cell synthesizes and degrades distinct cyclin proteins—cyclin D, cyclin E, cyclin A, and cyclin B—in a temporally regulated sequence. Each cyclin–CDK dimer phosphorylates a targeted set of substrates, and those phosphorylation events alter substrate conformation, protein–protein interactions, or subcellular localization to advance the cell from one phase to the next. For example, the cyclin E–CDK2 complex phosphorylates the retinoblastoma protein (Rb), causing Rb to release the transcription factor E2F; liberated E2F then drives transcription of genes required for DNA replication at the G1-to-S transition. Later, cyclin B–CDK1 (also called MPF, or maturation-promoting factor) phosphorylates structural proteins such as nuclear lamins, triggering lamin depolymerization and nuclear envelope breakdown at the G2-to-M checkpoint. Phosphatases such as Cdc25 remove inhibitory phosphate groups on CDKs, while CKI proteins (p21, p27) bind cyclin–CDK complexes and block the catalytic cleft, adding additional regulatory layers. The net direction of this entire signaling architecture is forward momentum through G1, S, G2, and M phases, with checkpoint surveillance integrated at each transition.

Why Other Options Are Wrong

PILLAR 2 — STEP-BY-STEP LOGIC

The question stem asks which statement best describes the relationship between CDKs and the cell cycle based on available data. The mechanistic architecture outlined above leads directly to the conclusion that CDKs drive the cell cycle forward. At every major checkpoint—G1, the G1/S boundary, S phase, the G2/M boundary, and within mitosis itself—specific cyclin–CDK dimers phosphorylate precise substrates whose structural or functional modification moves the cell irreversibly toward the next phase. Degradation of each cyclin by the ubiquitin-proteasome system after its checkpoint has passed ensures that the kinase activity is unidirectional and time-limited, preventing the cell from slipping backward. The data would therefore show peaks of CDK activity coinciding with each phase transition, confirming that these enzymes actively propel cell-cycle progression rather than merely permitting or inhibiting it. Option B captures this directional, propulsive relationship accurately.

PILLAR 3 — DISTRACTOR ANALYSIS

Option A states that CDKs are only active during G1 phase. This is a phase-restriction trap: students who recall cyclin D–CDK4/6 complexes operating in early G1 may overgeneralize and forget that cyclin E–CDK2, cyclin A–CDK2, and cyclin B–CDK1 operate at the G1/S, S, and G2/M transitions respectively. The flaw is temporal myopia—ignoring the full oscillatory spectrum of cyclin expression. Option C claims that CDKs only inhibit cell cycle progression. This reverses the functional polarity of kinase action; while CDK inhibitors (CKIs) like p21 do restrain the cycle, the CDKs themselves phosphorylate substrates that actively promote phase advancement. A student might confuse CDKs with their negative regulators and select this option. Option D asserts that CDKs are not essential for cell cycle progression. This contradicts foundational experimental evidence: yeast mutants lacking functional CDK genes arrest at checkpoint barriers and cannot divide, and human cells treated with CDK inhibitors such as roscovitine halt in G1 or G2. The flaw is an underestimate of regulatory necessity—confusing redundancy among specific cyclin–CDK pairs with dispensability of the entire kinase family.

In sum, cyclin-dependent kinases phosphorylate targeted substrates at each checkpoint, converting extracellular growth signals and internal readiness cues into irreversible structural changes that push the cell cycle forward, making option B the correct and best-supported choice.